by editor | Jul 2, 2020 | Clinicians, Media, Participants, Researchers
Statins may prevent heart attacks and strokes but may not prolong life free of disability PRESS RELEASE 2nd JULY 2020 A new observational study shows the first-line cholesterol-lowering drugs known as statins are associated with fewer heart attacks and...
by editor | Jun 4, 2020 | Clinicians, Participants, Researchers
ASPREE-D sub-study finds daily aspirin not protective against late-life depression PRESS RELEASE: 4th June 2020 Taking low-dose aspirin daily does not prevent depression in healthy older adults, according to new findings from researchers at the ASPREE (ASPirin...
by editor | Apr 1, 2020 | Clinicians, Participants, Researchers
Daily low-dose aspirin does not prevent cognitive decline in healthy older adults PRESS RELEASE: 1st April 2020 Researchers at Monash University and the Berman Center for Outcomes and Clinical Research in the US, have found that daily aspirin does not...
by editor | Dec 19, 2019 | Clinicians, Participants
A year of major achievements for long-term aspirin study This year, we welcomed a mid-year announcement that the NIA (National Institute on Aging) in the US would be funding the follow-up ASPREE-XT (eXTension) study for a further five years. Funding...
by editor | Aug 13, 2019 | Clinicians, Participants, Researchers
Impact of ASPREE trial on public health recognised We are pleased to share three Australian research accolades recently awarded to the ASPREE clinical trial for its significance to public health. ASPREE team acknowledged the contribution of participants,...
Recent Comments